Real-world Study of First Line Pembrolizumab- or Nivolumab-treated HPV-positive Recurrent/Metastatic Oropharyngeal Squamous Cell Carcinoma
Clinical trial NCT06771674 · COMPLETED
Trial details
- NCT number
- NCT06771674
- Sponsor
- Hookipa Biotech GmbH
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-06-05
- Primary completion
- 2025-02-28
- Enrollment
- 662
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.